Search Results

There are 4847 results for: content related to: Letter

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 50–65, C. Bradley and C. J. B. Gilbride

    Article first published online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00871.x

  2. Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 14–23, C. Mathieu and S. Robbrecht

    Article first published online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00841.x

  3. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 66–75, P. Levin

    Article first published online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00845.x

  4. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 5, September 2007, Pages: 648–659, T. Heise and T. R. Pieber

    Article first published online : 21 JUL 2007, DOI: 10.1111/j.1463-1326.2007.00756.x

  5. Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 11, November 2009, Pages: 1068–1079, T. Mittendorf, J. Smith-Palmer, L. Timlin, M. Happich and G. Goodall

    Article first published online : 3 SEP 2009, DOI: 10.1111/j.1463-1326.2009.01099.x

  6. Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 24–34, S. A. Schreiber

    Article first published online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00842.x

  7. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 5, May 2008, Pages: 387–399, M. Davies, F. Lavalle-González, F. Storms and R. Gomis, AT.LANTUS Study Group

    Article first published online : 18 MAR 2008, DOI: 10.1111/j.1463-1326.2008.00873.x

  8. Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 711–717, G. G. Rhoads, M. P. Dain, Q. Zhang and L. Kennedy

    Article first published online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01394.x

  9. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7–8% A1c levels. The TULIP study

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 4, April 2009, Pages: 379–386, J-F. Blicklé, N. Hancu, M. Piletic, V. Profozic, M. Shestakova, M-P. Dain, S. Jacqueminet and A. Grimaldi

    Article first published online : 14 DEC 2008, DOI: 10.1111/j.1463-1326.2008.00980.x

  10. Insulin analogues: an example of applied medical science

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 1, January 2009, Pages: 5–19, B. Sheldon, D. Russell-Jones and J. Wright

    Article first published online : 22 DEC 2008, DOI: 10.1111/j.1463-1326.2008.01015.x

  11. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 9, September 2010, Pages: 772–779, P. D. Home, A. Fritsche, S. Schinzel and M. Massi-Benedetti

    Article first published online : 23 APR 2010, DOI: 10.1111/j.1463-1326.2010.01232.x

  12. Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 42–49, M. Davies and K. Khunti

    Article first published online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00844.x

  13. Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 2, Issue 6, December 2000, Pages: 373–383, S. Dagogo-Jack, H. Askari, B. Morrill, L. L. Lehner, B. Kim and X. Sha

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1463-1326.2000.00109.x

  14. Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 10, October 2010, Pages: 916–922, K. Strojek, C. Shi, M. A. Carey and S. J. Jacober

    Article first published online : 23 JUN 2010, DOI: 10.1111/j.1463-1326.2010.01257.x

  15. Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 12, December 2011, Pages: 1149–1157, V. Koivisto, S. Cleall, A. E. Pontiroli and D. Giugliano

    Article first published online : 27 OCT 2011, DOI: 10.1111/j.1463-1326.2011.01484.x

  16. Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 11, November 2008, Pages: 1105–1113, R. H. A. Becker, A. D. Frick, L. Teichert, L. Nosek, L. Heinemann, T. Heise and K. Rave

    Article first published online : 18 MAR 2008, DOI: 10.1111/j.1463-1326.2008.00874.x

  17. You have free access to this content
    Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER study

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 2, February 2010, Pages: 115–123, A. Fritsche, M. Larbig, D. Owens and H.-U. Häring, on behalf of the GINGER study group

    Article first published online : 6 NOV 2009, DOI: 10.1111/j.1463-1326.2009.01165.x

    Corrected by:

    Erratum

    Vol. 12, Issue 11, 1022, Article first published online: 30 SEP 2010

  18. You have free access to this content
    Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 1, January 2009, Pages: 69–71, A. B. King

    Article first published online : 22 DEC 2008, DOI: 10.1111/j.1463-1326.2008.01014.x

  19. Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 7, July 2012, Pages: 626–633, M. Pawaskar, Q. Li, B. J. Hoogwerf, M. W. Reynolds, D. Faries, W. Engelman, D. Bruhn and R. M. Bergenstal

    Article first published online : 8 MAR 2012, DOI: 10.1111/j.1463-1326.2012.01581.x

  20. Insulin therapy in type 2 diabetes: what is the evidence?

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 5, May 2009, Pages: 415–432, Mariëlle J. P. Van Avendonk and Guy E. H. M Rutten

    Article first published online : 19 JAN 2009, DOI: 10.1111/j.1463-1326.2008.00981.x

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >